ALK GENE TRANSLOCATION

Clinical trials for ALK GENE TRANSLOCATION explained in plain language.

Never miss a new study

Get alerted when new ALK GENE TRANSLOCATION trials appear

Sign up with your email to follow new studies for ALK GENE TRANSLOCATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted drug trial aims to stop lung Cancer's comeback

Disease control Ongoing

This study is testing if a drug called crizotinib can help prevent early-stage lung cancer from coming back after surgery. It is for patients whose cancer has a specific genetic change called ALK-positive. After surgery, participants are randomly assigned to either take the drug …

Matched conditions: ALK GENE TRANSLOCATION

Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

ALK GENE TRANSLOCATION

Get alerted when new ALK GENE TRANSLOCATION trials appear

Targeted drug trial aims to stop lung Cancer's comeback